Status:
WITHDRAWN
GAG Replacement vs URethral DIlAtatioN
Lead Sponsor:
Hampshire Hospitals NHS Foundation Trust
Conditions:
Recurrent Urinary Tract Infection
Eligibility:
FEMALE
Phase:
NA
Brief Summary
The aim of this randomised parallel trial is to compare the efficacy of Glycosaminoglycan layer replacement against cystoscopy and urethral dilatation in the treatment of recurrent urinary tract infec...
Detailed Description
Recurrence of a Urinary Tract Infection (UTI) is defined as infection, following complete resolution of a previous UTI.Recurrent UTI (rUTI) is defined as 3 or more microbiologically confirmed UTI with...
Eligibility Criteria
Inclusion
- Female
- Pre-menopausal 3 - 3 episodes of cystitis in the last 12 months as defined by:
- 3 symptoms from dysuria, frequency, urgency, suprapubic tenderness, haematuria, polyuria
- Or less than 2 symptoms from the above list, but with cloudy urine 4 - Normal flow studies with bladder residual \<150ml 5 - Normal renal tract on USS
Exclusion
- \- Anatomical anomalies of urinary tract
- \- Neurological condition
- \- Diabetes mellitus
- \- Pregnancy
- \- Use of Immunosuppressants
- \- Symptomatic of UTI at time of treatment
Key Trial Info
Start Date :
April 30 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 28 2019
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT03861260
Start Date
April 30 2019
End Date
October 28 2019
Last Update
September 27 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hampshire Hospitals NHS Foundation Trust
Basingstoke, Hampshire, United Kingdom, RG24 9NA